Evolus’ injectable neurotoxin, Jeuveau, which was approved in 2019 and rivals AbbVie's major blockbuster Botox, knows exactly what it is. It’s an aesthetic product and that’s all it wants to be: no ...

Neurotoxin injectables have become one of the most common non-surgical cosmetic treatments for smoothing wrinkles and ...

Crows' feet, frown lines, and forehead creases are all signs of a life full of facial expressions. And while some may be reminders of happy memories, it's also totally fine to want to smooth them away ...

Evolus is shaking up promotion of its Botox rival. The old campaign was supporting above-market growth of wrinkle-busting product Jeuveau, but Evolus wants more, leading it to launch new branding ...

When it comes to a scraped knee, you probably reach for a Band-Aid. Sneeze attack? Kleenex, please! Sometimes a brand is so good, so ubiquitous, that it defines an industry. The same could be said for ...

Evolus, Inc., a pharmaceutical company specializing in aesthetic products, faces significant challenges with its lead product Jeuveau, a treatment for frown lines. Jeuveau's undifferentiated clinical ...

The secret to wrinkle-free, smooth skin isn’t so secret in today’s day and age. More than ever, people are turning to Botox or other neurotoxin injections, the muscle relaxers that help prevent and ...

Company launches bold rebrand of Jeuveau® (prabotulinumtoxinA-xvfs), a modern-made neurotoxin dedicated exclusively for aesthetics Jeuveau® has been the fastest-growing neurotoxin in the U.S. for two ...

Please provide your email address to receive an email when new articles are posted on . New phase 2 results showed 40 units of Jeuveau sustained improvements in glabellar lines up to 6 months. Adverse ...

When I say I’ve been getting Botox my entire adult life, I’m not exaggerating one bit—I started at the ripe, young age of 19 to help prevent wrinkles from forming, and I’ve honestly never looked back.

It took four experts, lots of needles and hundreds of units, but it finally worked.